ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Gene Therapy and Antisense Drugs Market Scope and Revenue Outlook For Forecast to 2025 – Medgadget (blog)

Continue reading

2017-08-16 Michael Zand NEWS

Global Immunotherapy Drugs Market 2017 top players : ELI Lilly and Company, Novartis International, Bristol-Myers … – Medgadget (blog)

Medgadget (blog)Global Immunotherapy Drugs Market 2017 top players : ELI Lilly and Company, Novartis International, Bristol-Myers …Medgadget (blog)The Market Research Store report offers majority of the latest and newest industry data that covers the… Continue reading

2017-08-16 Michael Zand NEWS

Matching mutations to immunotherapy response – Nature.com

Matching mutations to immunotherapy responseNature.comThe presence of mismatch repair (MMR) deficiency could be used as a predictor of response of solid tumours to PD-1 (programmed cell death protein 1) blockade immunotherapy, according to a report pub… Continue reading

2017-08-16 Michael Zand NEWS

CAR T-Cell Therapies for Hematologic Malignancies Moving Toward the Clinic – Targeted Oncology

CAR T-Cell Therapies for Hematologic Malignancies Moving Toward the ClinicTargeted OncologyUpdated results from ZUMA-3, a phase 1/2 study of KTE-C19 chimeric antigen receptor (CAR) T cell therapy, in adults with high-burden relapsed/refrac- tory acute … Continue reading

2017-08-16 Michael Zand NEWS

CAR T-Cell Therapies for Hematologic Malignancies Moving Toward the Clinic – Targeted Oncology

CAR T-Cell Therapies for Hematologic Malignancies Moving Toward the ClinicTargeted OncologyUpdated results from ZUMA-3, a phase 1/2 study of KTE-C19 chimeric antigen receptor (CAR) T cell therapy, in adults with high-burden relapsed/refrac- tory acute … Continue reading

2017-08-16 Michael Zand NEWS

CAR T-Cell Therapies for Hematologic Malignancies Moving Toward the Clinic – Targeted Oncology

Gene Therapy and Antisense Drugs Market Scope and Revenue Outlook For Forecast to 2025
Medgadget (blog)
Since an escalating number of patients are being diagnosed with cancer every day, the global demand for gene therapy and antisense drugs is bound to multiply. The growing incidence of health conditions such as Parkinson’s disease and high cholesterol …

Continue reading

2017-08-16 Michael Zand NEWS

Pfizer to expand in Sanford for gene-therapy medications – Palmetto Business Daily

CAR T-Cell Therapies for Hematologic Malignancies Moving Toward the Clinic
Targeted Oncology
Updated results from ZUMA-3, a phase 1/2 study of KTE-C19 chimeric antigen receptor (CAR) T cell therapy, in adults with high-burden relapsed/refrac- tory acute lymphoblastic leukemia (R/R ALL). J Clin Oncol. 2017;35(suppl; abstr 3024). Locke FL …
Global CAR T Cell Therapy Market, By Targeted Antigen, Therapeutic Application, and Geography – Trends, Analysis …Medgadget (blog)

all 2 news articles »

Continue reading

2017-08-16 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Sees Significantly Higher Trading Volume – Modern Readers

Key GazetteEditas Medicine, Inc. (NASDAQ:EDIT) Sees Significantly Higher Trading VolumeModern ReadersCRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Pr… Continue reading

2017-08-16 Michael Zand NEWS
  • 1
  • …
  • 1,352
  • 1,353
  • 1,354
  • 1,355
  • 1,356
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Pfizer to expand in Sanford for gene–therapy medications
Palmetto Business Daily
Gene therapy focuses on specialized, one-time treatments to address diseases caused by genetic mutation. In gene therapy, new genetic material is introduced into the body to correct a patient’s cells as needed. “Pfizer is proud to further expand our …